1981
Autoimmune disease doctor
Tireless leadership in the fight against infectious diseases →
BONAVENTURA CLOTET
“
Over the last 30 years, we have acquired a great deal of knowledge about HIV, thanks to which we can now fight against other infectious diseases that also affect the immune system.”
Bonaventura Clotet,
President
Bonaventura Clotet, born in Barcelona in 1953, holds a PhD in Medicine from the Autonomous University of Barcelona. He is President of the Fundació Lluita contra les Infeccions, Director of the AIDS Research Institute (IrsiCaixa) and territorial director on Infectious Diseases in the management of the Northern Metropolitan Area of the Catalan Institute of Health (ICS).
In 1981, during his residency as a specialist in Internal Medicine at the Vall d’Hebron University Hospital in Barcelona, he happened to be there for the first case of AIDS in Spain. This event left its mark on him professionally and led him to lead the HIV Unit of the Germans Trias i Pujol University Hospital in Badalona. He is currently in charge of a team of more than 200 people who fight every day to do more for infectious diseases.
OUTSTANDING TRAJECTORY
1987-2015
Head of the HIV Unit at Germans Trias Hospital
1992
Creates and chairs the Fight Against Infections Foundation
1995
Director of the IrsiCaixa Research Institute
2021
National Research Award of Catalonia
2022
Territorial Clinical Director of Infectious Diseases/MetroNord Management/ICS
National and international recognition for a brilliant career
He has been a member of the Drug Resistance Mutations Group (IAS-USA) for 10 years and the Governing Council of the International Aids Society (IAS). His professional activity has also earned him recognition from the Catalan Institute of Health (ICS), which in 2010 awarded him the Scientific Career Award at ICS Hospitals.
In 2013 he received the Award for Professional Excellence from the Official College of Physicians of Barcelona (COMB) and in 2021 he was recognised with the Catalan National Research Award.
+1000
Articles in international magazines
+5000
Cumulative impact factor
+57.000
Citations in articles
Scientific advice for business project excellence
He is currently a scientific advisor to AELIX Therapeutics (2015) for the development of a therapeutic vaccine against HIV, to AlbaJuna Therapeutics (2016) for the development of an immunoglobulin to cure and prevent HIV, and to the DooleHealth (2015) telemedicine platform that strengthens the relationship between patients and health professionals.